Facile synthesis of various nitro-substituted derivatives of Semaxinib (SU5416)

Synthetic Communications

Volumn 38, Issue 17, 2008, Pages 3017-3022

  Kniess, Torsten ^a   Kuchar, Manuela ^a   Wuest, Frank ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Nitration; Semaxinib; Tyrosine kinase

Indexed keywords

3 [(2',4' DIMETHYLPYRROL 3' NITRO 5' YL)METHYLINDENYL] 5 FLUORO INDOLIN 2 ONE; 3 [(2',4' DIMETHYLPYRROL 3' NITRO 5' YL)METHYLINDENYL] 5 NITRO INDOLIN 2 ONE; 3 [(2',4' DIMETHYLPYRROL 3' NITRO 5' YL)METHYLINDENYL]INDOLIN 2 ONE; 3 [(2',4' DIMETHYLPYRROL 5' YL)METHYLINDENYL] 5 NITRO INDOLIN 2 ONE; 3,5 DIMETHYL 4 NITROPYRROL 2 CARBALDEHYDE; 3,5 DIMETHYLPYRROL 2 CARBALDEHYDE; 5 FLUORO OXINDOLE; 5 NITRO OXINDOLE; ALDEHYDE DERIVATIVE; INDOLE DERIVATIVE; OXINDOLE; SEMAXANIB; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; KNOEVENAGEL CONDENSATION; NITRATION; SUBSTITUTION REACTION;

EID: 50649115725     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910802044256     Document Type: Article

References (12)

1. Mendel, D. B.; Laird, D.; Smolich, B. D.; Blake, R. A.; Liang, C.; Hannah, A. L.; Shaheen, R. M.; Ellis, L. M.; Weitman, S.; Shawver, L. K.; Cherrington, J. M. Development of SU 5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anti-Cancer Drug Design 2000, 15, 29.
2. Takamoto, T.; Sasaki, M.; Kuno, T.; Tamaki, N. Flk-1 specific kinase inhibitor (SU5416) inhibited the growth of GS-9L glioma in rat brain and prolonged survival. Kobe J. Med. Sci. 2001, 47, 181.
3. Stadler, W. M.; Cao, D.; Vogelzang, N. J.; Ryan, C. W.; Hoving, K.; Wright, R.; Karrison, T.; Vokes, E. E. A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin. Cancer Res. 2004, 10, 3365.
4. Peterson, A. C.; Swiger, S.; Stadler, W. M.; Medved, M.; Karczmar, G.; Gajewski, T. F. Phase II study of the FLK-1 tyrosine kinase inhibitor SU 5416 in advanced melanoma. Clin. Cancer Res. 2004, 10, 4048.
5. Sun, L.; Tran, N.; Tang, F.; App, H.; Hirth, P.; McMahon, G.; Tang, C. Synthesis and biological evaluations of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J. Med. Chem. 1998, 41, 2588.
6. Sun, L.; Liang, C.; Shirazian, S.; Zhou, Y.; Miller, T.; Cui, J.; Fukuda, J. Y.; Chu, J. -Y.; Nematalla, A.; Wang, X.; Chen, H.; Sistla, A.; Luu, T. C.; Tang, F.; Wei, J.; Tang, C. Discovery of 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z) -ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl) amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. J. Med. Chem. 2003, 46, 1116.
7. Weber, W. A.; Haubner, R.; Vabuline, E.; Kuhnast, B.; Wester, H. J.; Schwaiger, M. Tumor angiogenesis targeting using imaging agents. Q. J. Nucl. Med. 2001, 45, 179.
8. Coenen, H. H. Fluorine-18 labeling methods: Features and possibilities of basic reactions, In PET Chemistry - The Driving Force in Molecular Medicine; Ernst Schering Research Foundation Workshop 62; Springer: Berlin, 2007; p. 15.
9. Sumpter, W. C.; Miller, M.; Magan, M. E. The structure of Baeyer's Nitro-oxindole. J. Am. Chem. Soc. 1945, 67, 499.
10. Baeyer, A. Untersuchungen über die Gruppe des Indigblaus. Ber. Deutsch. Chem. Ges. 1879, 12, 1309.
11. Clezy, P. S.; Liepa, A. J.; Webb, N. W. The chemistry of pyrrolic compounds XXIII: β-Aminoporphyrins and their derivatives. Aust. J. Chem. 1972, 25, 2687.
12. Hrabovsky, J.; Kovac, J.; Vagacova, K. Preparation of N-methyl-5-nitro-2-pyrrolvinyl bromide. Coll. Czech. Chem. Commun. 1986, 51, 1301.